Literature DB >> 4251268

Antibody responses to influenza vaccine in patients with Down's syndrome.

M C Gordon, S K Sinha, S D Carlson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4251268

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


× No keyword cloud information.
  7 in total

1.  Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome.

Authors:  S Li Volti; T Mattina; L Mauro; S Bianca; S Anfuso; A Ursino; F Mollica
Journal:  Childs Nerv Syst       Date:  1996-02       Impact factor: 1.475

2.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

3.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

4.  Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome).

Authors:  T Nurmi; M Leinonen; V M Häivä; A Tiilikainen; K Kouvalainen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

5.  Immune function in patients with chromosome deletions.

Authors:  T Nurmi; M Uhari; S L Linna; S Silvennoinen-Kassinen; M Koskela; J Kiuttu; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

6.  Immunological and virological investigations in Down's syndrome.

Authors:  G Fekete; G Kulcsár; P Dán; I Nász; D Schuler; M Dobos
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

7.  The antibody response of institutionalized Down's syndrome patients to seven microbial antigens.

Authors:  R A Hawkes; C R Boughton; D R Schroeter
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.